FDA.reportPublic FDA data

Gilotrif 30 MG Oral Tablet

RxCUI
1430453
RxNorm name
Gilotrif 30 MG Oral Tablet
Display name
Gilotrif 30 MG Oral Tablet
Full name
Gilotrif 30 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GilotrifAFATINIBBoehringer Ingelheim Pharmaceuticals, Inc.fd638e5e-8032-e7ca-0179-95e96ab5d3872025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 1430453

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fd638e5e-8032-e7ca-0179-95e96ab5d387Gilotrif 30 MG Oral Tablet [PSN] · afatinib 30 MG Oral Tablet [Gilotrif] [SBD] · Gilotrif 30 MG (as afatinib dimaleate 44.34 MG) Oral Tablet [SY] · Gilotrif 30 MG Oral Tablet [SY]420These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. GILOTRIF ® (afatinib tablets), for oral use Initial U.S. Approval: 201320251113